← All stocks

Dianthus Therapeutics, Inc. /DE/

DNTH Scheduled selling only
CIK 0001690585 #1220 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$69.18M
$0.00 on a plan · $69.18M straight out of an exercise
Sold at will
$0.00
0 of 61 sales
Net
−$69.18M
$0.00 against sales at will

By person

9 insiders · 64 transactions
11.0×

Marino Garcia holds 11.0 times base salary in stock. $6.97M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marino Garcia last reported holding, valued at $106.74, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Garcia Marino
CEO AND PRESIDENT
$27.96M (12) scheduled
−$27.96M
65,292
0.1167%
$6.97M
Randhawa Simrat
EVP, Head of R&D
$15.00M (11) scheduled
−$15.00M
4,000
0.0072%
$426.96K
0.0%
Savitz Ryan
EVP, CFO & CBO
$14.29M (13) scheduled
−$14.29M
0
0.0000%
$0.00
Veness Adam M
SVP, General Counsel and Sec.
$4.63M (5) scheduled
−$4.63M
15,000
0.0268%
$1.60M
CARR EDWARD
CHIEF ACCOUNTING OFFICER
$3.56M (5) scheduled
−$3.56M
0
0.0000%
$0.00
Soteropoulos Paula
Director
$2.25M (3) scheduled
−$2.25M
0
0.0000%
$0.00
McGeorge Anne
Director
$844.82K (5) scheduled
−$844.82K
0
0.0000%
$0.00
Read Simon
Director
$630.79K (7) scheduled
−$630.79K
0
0.0000%
$0.00
Fairmount Funds Management LLC entity
Director
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
Randhawa Simrat
1 Sep 2026
EVP, Head of R&D
Sold after exercise
13,309
$106.74
$1.42M
Randhawa Simrat
1 Sep 2026
EVP, Head of R&D
Sold after exercise
7,215
$106.25
$766.59K
Randhawa Simrat
1 Sep 2026
EVP, Head of R&D
Sold after exercise
2,600
$105.19
$273.49K
Read Simon
19 Aug 2026
Director
Sold after exercise
2,778
$117.55
$326.55K
Veness Adam M
13 Aug 2026
SVP, General Counsel and Sec.
Exercised, kept
15,000
$18.17
$272.55K
Veness Adam M
10 Aug 2026
SVP, General Counsel and Sec.
Sold after exercise
16,167
$110.38
$1.78M
Read Simon
10 Aug 2026
Director
Sold after exercise
397
$111.77
$44.37K
Read Simon
10 Aug 2026
Director
Sold after exercise
470
$111.05
$52.19K
Read Simon
10 Aug 2026
Director
Sold after exercise
272
$109.96
$29.91K
Read Simon
10 Aug 2026
Director
Sold after exercise
831
$108.95
$90.54K
Read Simon
10 Aug 2026
Director
Sold after exercise
737
$108.17
$79.72K
Read Simon
10 Aug 2026
Director
Sold after exercise
70
$107.11
$7.50K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
700
$111.41
$77.99K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
1,000
$110.64
$110.64K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
1,800
$109.30
$196.74K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
2,800
$108.38
$303.46K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
1,450
$107.58
$155.99K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
21,909
$108.72
$2.38M
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
104,091
$107.96
$11.24M
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
800
$110.76
$88.61K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
2,536
$110.02
$279.01K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
2,373
$109.10
$258.89K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
23,907
$108.05
$2.58M
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
10,384
$107.49
$1.12M
Veness Adam M
7 Aug 2026
SVP, General Counsel and Sec.
Sold after exercise
616
$111.18
$68.49K
Veness Adam M
7 Aug 2026
SVP, General Counsel and Sec.
Sold after exercise
3,217
$110.61
$355.83K
Savitz Ryan
9 Jul 2026
EVP, CFO & CBO
Sold after exercise
5,566
$101.97
$567.57K
Savitz Ryan
9 Jul 2026
EVP, CFO & CBO
Sold after exercise
15,329
$101.24
$1.55M
Savitz Ryan
9 Jul 2026
EVP, CFO & CBO
Sold after exercise
10,354
$100.22
$1.04M
Veness Adam M
17 Jun 2026
SVP, General Counsel and Sec.
Sold after exercise
13,229
$81.38
$1.08M
Veness Adam M
17 Jun 2026
SVP, General Counsel and Sec.
Sold after exercise
16,771
$80.34
$1.35M
Randhawa Simrat
1 Jun 2026
EVP, Head of R&D
Sold after exercise
4,159
$91.37
$380.01K
Randhawa Simrat
1 Jun 2026
EVP, Head of R&D
Sold after exercise
16,943
$90.72
$1.54M
Randhawa Simrat
1 Jun 2026
EVP, Head of R&D
Sold after exercise
5,428
$89.72
$487.00K
Soteropoulos Paula
8 May 2026
Director
Sold after exercise
599
$85.47
$51.20K
Savitz Ryan
9 Apr 2026
EVP, CFO & CBO
Sold after exercise
8,224
$89.84
$738.84K
Soteropoulos Paula
31 Mar 2026
Director
Sold after exercise
599
$80.11
$47.99K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
7,232
$85.54
$618.63K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
19,469
$84.57
$1.65M
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
59,800
$83.90
$5.02M
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
2,366
$82.84
$196.00K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
800
$81.36
$65.09K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
1,485
$80.25
$119.17K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
21,825
$78.86
$1.72M
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
1,390
$78.33
$108.88K
Soteropoulos Paula
24 Mar 2026
Director
Sold after exercise
27,594
$78.05
$2.15M
Garcia Marino
16 Mar 2026
CEO AND PRESIDENT
Exercised, kept
5,592
$17.88
$99.98K
Garcia Marino
16 Mar 2026
CEO AND PRESIDENT
Exercised, kept
59,700
$6.70
$399.99K
Randhawa Simrat
12 Mar 2026
EVP, Head of R&D
Sold after exercise
33,830
$81.48
$2.76M
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
300
$85.53
$25.66K
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
200
$83.38
$16.68K
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
3,865
$82.66
$319.48K
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
23,465
$81.75
$1.92M
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
15,852
$80.71
$1.28M
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
900
$85.53
$76.98K
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
200
$83.38
$16.68K
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
12,796
$82.60
$1.06M
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
65,517
$81.74
$5.36M
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
43,505
$80.69
$3.51M
Savitz Ryan
4 Dec 2025
CFO & CBO
Sold after exercise
20,000
$45.18
$903.60K
Randhawa Simrat
14 Nov 2025
EVP, Head of R&D
Sold after exercise
109,031
$38.14
$4.16M
Randhawa Simrat
13 Nov 2025
EVP, Head of R&D
Sold after exercise
18,576
$37.72
$700.69K
Randhawa Simrat
13 Nov 2025
EVP, Head of R&D
Sold after exercise
42,765
$37.04
$1.58M
Randhawa Simrat
13 Nov 2025
EVP, Head of R&D
Sold after exercise
26,166
$35.80
$936.74K

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 61
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 958,851
History held since 27 Jun 2018